Cited by 1713D Printing in Biomedical ResearchMicrofluidic and Capillary Electrophoresis ApplicationsTissue Engineering and Regenerative Medicine

High-throughput organ-on-a-chip systems: Current status and remaining challenges

Open access
Probst, Christopher, Schneider, Stefan, Loskill, Peter·2018·Current Opinion in Biomedical Engineering

Abstract

Organ-on-a-chip (OoC) systems might be the disruptive technology pharmaceutical industry has been looking for to tackle their ever-increasing R&D costs. First endeavors are well underway to transfer this technology, which was until now used solely in academic settings, to industry. The high hopes of the OoC technology stem inter alia from its potential to merge strengths of animal models and cell culture, i.e., high physiological relevance and high throughput capacity. However, although the predictive value and physiological character of various OoC systems have been highlighted in numerous studies, the applicability for medium or even high-throughput screenings (HTS) has not been demonstrated yet. Adaptations such as massive parallelization and automation are among the biggest challenges in attempts to meet industrial benchmarks of HTS. In this review, we briefly introduce the demands of modern-day HTS in drug discovery and development, review the status-quo of parallelized OoC systems, and discuss the current limitation and remaining challenges that need to be overcome to increase the throughput of OoC experiments.

Integrity signals

Registry

Crossref · 10.1016/j.cobme.2018.02.004

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher throughput across the entire fabrication, culture and analysis pipeline accelerates screening campaigns and increases statistical power.

    “Higher throughput across the entire fabrication, culture and analysis pipeline accelerates screening campaigns and increases statistical power (Probst et al., 2018).”
  • The hiPSC-based RoC avoids the problem of limited supply and provides the capability to create a multitude of genetically identical systems and sets the foundation for scale-up to higher throughput systems, provided an appropriate framework and automated process landscape is established.

    “This not only avoids the problem of limited supply but also provides the capability to create a multitude of genetically identical systems and sets the foundation for a scale-up to higher throughput systems, provided an appropriate framework and an automated process landscape is established (Probst et al., 2018).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Probst, C., Schneider, S., & Loskill, P.
Affiliations
Fraunhofer Institute for Interfacial Engineering and Biotechnology (DE)
Corresponding author
Loskill, Peter
Venue
Current Opinion in Biomedical Engineering
Publisher
Elsevier BV
Published
2018-06
Volume
6
Pages
33-41
ISSN
2468-4511 (ISSN-L)
OpenAlex
W2792993918
Cited by
171
References
50
Citations by year
2026: 17 · 2025: 18 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 32 · 2020: 14 · 2019: 15 · 2018: 6
FWCI
1.36
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Biomedical Engineering (publishedVersion, cc-by-nc)
  • Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
  • Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders
Horizon 2020 (766884)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
organ-on-a-chip, high-throughput screening, parallelization, automation, drug discovery, drug development, in vitro model, physiological relevance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review